![Wayne Caulder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wayne Caulder
Plus aucun poste en cours
Profil
Wayne Caulder worked as a Sales Director at ISTA Pharmaceuticals, Inc., Vice President-Sales at Samsara Vision, Inc., and Head-Sales at Ciba Vision Ophthalmics Co. He obtained an undergraduate degree from Appalachian State University.
Anciens postes connus de Wayne Caulder
Sociétés | Poste | Fin |
---|---|---|
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Sales & Marketing | - |
Ciba Vision Ophthalmics Co. | Sales & Marketing | - |
SAMSARA VISION, INC. | Sales & Marketing | - |
Formation de Wayne Caulder
Appalachian State University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 3 |
---|---|
Samsara Vision, Inc.
![]() Samsara Vision, Inc. Medical SpecialtiesHealth Technology Samsara Vision, Inc. engages in the business of research, development, manufacturing, and marketing proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. It operates under the United States and Other geographical segments. The company was founded by Isaac Lipshitz, David Lifschitz, Yossi Gross, Boaz Lifschitz, and Eyal Lifschitz in 1997 and is headquartered in Far Hills, NJ. | Health Technology |
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Ciba Vision Ophthalmics Co. |